Recce Pharmaceuticals (ASX:RCE) ended the June quarter with a cash balance of AU$2.9 million, according to a Tuesday filing with the Australian bourse.
The company closed the March quarter with a cash balance of AU$1.7 million, an earlier filing showed.
During the June quarter, Recce saw net cash outflows from operating activities of AU$2.2 million, with research and development accounting for the majority of that spend.
The company's shares gained 1% in recent Tuesday trade.